Breedlove Robert Charles sold PHAT

September 5, 2025 · Form 4 insider transaction

Breedlove Robert Charles sold 461 shares of Phathom Pharmaceuticals, Inc. at $12.09 per share, a transaction worth $5.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
461
Price
$12.09
Total value
$5.6K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateSeptember 9, 2025
Shares owned after47,931
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

View the original Form 4 on SEC EDGAR
Breedlove Robert Charles sold PHAT: September 5, 2025 | Insider Trading Screener